Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment
Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague 6, Czech Republic
*
Author to whom correspondence should be addressed.
Pharmaceutics 2019, 11(9), 471; https://doi.org/10.3390/pharmaceutics11090471
Received: 2 August 2019
/
Revised: 29 August 2019
/
Accepted: 4 September 2019
/
Published: 12 September 2019
(This article belongs to the Special Issue Advanced Polymeric Delivery Systems for Cancer Therapy)
Targeted drug delivery using nano-sized carrier systems with targeting functions to malignant and inflammatory tissue and tailored controlled drug release inside targeted tissues or cells has been and is still intensively studied. A detailed understanding of the correlation between the pharmacokinetic properties and structure of the nano-sized carrier is crucial for the successful transition of targeted drug delivery nanomedicines into clinical practice. In preclinical research in particular, fluorescence imaging has become one of the most commonly used powerful imaging tools. Increasing numbers of suitable fluorescent dyes that are excitable in the visible to near-infrared (NIR) wavelengths of the spectrum and the non-invasive nature of the method have significantly expanded the applicability of fluorescence imaging. This chapter summarizes non-invasive fluorescence-based imaging methods and discusses their potential advantages and limitations in the field of drug delivery, especially in anticancer therapy. This chapter focuses on fluorescent imaging from the cellular level up to the highly sophisticated three-dimensional imaging modality at a systemic level. Moreover, we describe the possibility for simultaneous treatment and imaging using fluorescence theranostics and the combination of different imaging techniques, e.g., fluorescence imaging with computed tomography.
View Full-Text
Keywords:
fluorescence imaging; drug delivery; polymers; noninvasive imaging; theranostics
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Etrych, T.; Janoušková, O.; Chytil, P. Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment. Pharmaceutics 2019, 11, 471. https://doi.org/10.3390/pharmaceutics11090471
AMA Style
Etrych T, Janoušková O, Chytil P. Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment. Pharmaceutics. 2019; 11(9):471. https://doi.org/10.3390/pharmaceutics11090471
Chicago/Turabian StyleEtrych, Tomáš, Olga Janoušková, and Petr Chytil. 2019. "Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment" Pharmaceutics 11, no. 9: 471. https://doi.org/10.3390/pharmaceutics11090471
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
